Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy

Min, Sang-Won, Cho, Seo-Hyun, Zhou, Yungui, Schroeder, Sebastian, Haroutunian, Vahram, Seeley, William W., Huang, Eric J., Shen, Yong +6 more·2010·Neuron

Cited by (959)

Items 301–400 of 959

  1. SIRT1 Regulation of Wakefulness and Senescence-Like Phenotype in Wake Neurons
    Lori A. Panossian, Polina Fenik, Yan Zhu, Guanxia Zhan, Michael W. McBurney, Sigrid Carlen Veasey · 2011 · Journal of Neuroscience
  2. SIRT1 Modulates Aggregation and Toxicity through Deacetylation of the Androgen Receptor in Cell Models of SBMA
    Heather L. Montie, Richard G. Pestell, Diane E. Merry · 2011 · Journal of Neuroscience
  3. Myc inhibition impairs autophagosome formation
    Pearl Pei Chern Toh, Shouqing Luo, Fiona M. Menzies, Tamás Raskó, Erich E. Wanker, David Chaim Rubinsztein · 2013 · Human Molecular Genetics
  4. UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation
    Manivannan Subramanian, Seung Jae Hyeon, Tanuza Das, Yoon Seok Suh, Yun Kyung Kim, Jeong-Soo Lee, Eun Joo Song, Hoon Ryu, Kweon Yu · 2021 · Nature Communications
  5. Acetylation, Phosphorylation, Ubiquitination (Oh My!): Following Post-Translational Modifications on the Ubiquitin Road
    Rachel E. Lacoursiere, Dania Hadi, Gary S. Shaw · 2022 · Biomolecules
  6. Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimer’s Disease
    Xin Wang, Helena R. Zimmermann, Tao Ma · 2019 · Journal of Alzheimer s Disease
  7. Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma
    Hussein Abou‐Abbass, Hadi Abou‐El‐Hassan, Hisham F. Bahmad, Kazem Zibara, Abir Zebian, Rabab Youssef, Joy N. Ismail, Rui Zhu, Shiyue Zhou, Xue Dong et al. · 2016 · Electrophoresis
  8. Contribution of Neuroepigenetics to Huntington’s Disease
    Laetitia Francelle, Caroline Lotz, Tiago F. Outeiro, Emmanuel Brouillet, Karine Mérienne · 2017 · Frontiers in Human Neuroscience
  9. Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer’s disease pathogenesis: Potential strategies to protect the LC against aging
    Akiko Satoh, Koichi Iijima · 2017 · Brain Research
  10. Degradation or aggregation: the ramifications of post-translational modifications on tau
    Seoyoung Park, Jung Hoon Lee, Jun Hyoung Jeon, Min Jae Lee · 2018 · BMB Reports
  11. Metabolic Regulation of Glia and Their Neuroinflammatory Role in Alzheimer's Disease
    Preeti Kumari, Anika Sood, Valencia Fernandes · 2021 · Cellular and Molecular Neurobiology
  12. Dapagliflozin as an autophagic enhancer via LKB1/AMPK/SIRT1 pathway in ovariectomized/d-galactose Alzheimer’s rat model
    Weam W. Ibrahim, Ahmed Seif El Din Kamel, Ahmed M. Wahid, Noha F. Abdelkader · 2022 · Inflammopharmacology
  13. Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues
    Raffaele Ferrari, Claudia Manzoni, John Hardy · 2019 · Neurobiology of Aging
  14. Exercise-Induced Benefits for Alzheimer’s Disease by Stimulating Mitophagy and Improving Mitochondrial Function
    Jiling Liang, Cenyi Wang, Hu Zhang, Jielun Huang, Juying Xie, Ning Chen · 2021 · Frontiers in Aging Neuroscience
  15. SIRT1 is a Highly Networked Protein That Mediates the Adaptation to Chronic Physiological Stress
    Michael W. McBurney, Katherine V. Clark-Knowles, Annabelle Z. Caron, Douglas A. Gray · 2013 · Genes & Cancer
  16. Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer’s and Parkinson’s Diseases
    Óscar Teijido, Ramón Cacabelos · 2018 · International Journal of Molecular Sciences
  17. Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy
    Jinwang Ye, Huali Wan, Sihua Chen, Gong‐Ping Liu · 2023 · Neural Regeneration Research
  18. RETRACTED: Redox regulation of cellular stress response in multiple sclerosis
    Giovanni Pennisi, Carolin Cornelius, Monia Cavallaro, Angela Trovato Salinaro, Maria Teresa Cambria, Manuela Pennisi, Rita Bella, Pietro Milone, Bernardo Ventimiglia, M.R. Migliore et al. · 2011 · Biochemical Pharmacology · Retracted
  19. Targeting heat shock proteins to modulate α-synuclein toxicity
    Daryl Rhys Jones, Simon Moussaud, Pamela J. McLean · 2013 · Therapeutic Advances in Neurological Disorders
  20. Sirtuins at the Service of Healthy Longevity
    Watroba, Mateusz, Szukiewicz, Dariusz · 2021 · Frontiers in Physiology
  21. Transcriptional Effects of ApoE4: Relevance to Alzheimer’s Disease
    Theendakara, Veena, Peters-Libeu, Clare A., Bredesen, Dale E., Rao, Rammohan V. · 2018 · Molecular Neurobiology
  22. Decoding neuroproteomics: integrating the genome, translatome and functional anatomy
    Kitchen, Robert R, Rozowsky, Joel S, Gerstein, Mark B, Nairn, Angus C · 2014 · Nature Neuroscience
  23. A mechanistic survey of Alzheimer's disease
    Yijing Tang, Dong Zhang, Xiong Gong, Jie Zheng · 2021 · Biophysical Chemistry
  24. Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation
    Mingming Zhang, Zhiyin Tang · 2023 · Biomedicine & Pharmacotherapy
  25. Intracellular and Extracellular Roles for Tau in Neurodegenerative Disease
    Diane P. Hanger, Dawn H. W. Lau, Emma Claire Phillips, Marie K. Bondulich, Tong Guo, Benjamin W. Woodward, Amy M. Pooler, Wendy J. Noble · 2014 · Journal of Alzheimer s Disease
  26. Silent Information Regulator 2 Homolog 1 Counters Cerebral Hypoperfusion Injury by Deacetylating Endothelial Nitric Oxide Synthase
    Yorito Hattori, Yoko Okamoto, Takakuni Maki, Yumi Yamamoto, Naoya Oishi, Kenichi Yamahara, Kazuyuki Nagatsuka, Ryōsuke Takahashi, Raj N. Kalaria, Hidenao Fukuyama et al. · 2014 · Stroke
  27. Proteomics of protein post-translational modifications implicated in neurodegeneration
    Ru‐Jing Ren, Eric B. Dammer, Gang Wang, Nicholas T. Seyfried, Allan I. Levey · 2014 · Translational Neurodegeneration
  28. Protein Tau: Prime Cause of Synaptic and Neuronal Degeneration in Alzheimer's Disease
    Natàlia Crespo‐Biel, Clara Theunis, Fred VAN LEUVEN · 2012 · International Journal of Alzheimer s Disease
  29. Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Sarah Fischer, Gail V.W. Johnson, Keith W. Nehrke · 2020 · Molecular Neurodegeneration
  30. Introducing ADNP and SIRT1 as new partners regulating microtubules and histone methylation
    Adva Hadar, Oxana Kapitansky, Maram Ganaiem, Shlomo Sragovich, Alexandra Lobyntseva, Eliezer Giladi, Adva Yeheskel, A Katz Avitan, Gad David Vatine, David Gurwitz et al. · 2021 · Molecular Psychiatry
  31. Systemic regulation of mammalian ageing and longevity by brain sirtuins
    Akiko Satoh, Shin‐ichiro Imai · 2014 · Nature Communications
  32. Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: The forgotten partner
    Isidró Ferrer · 2018 · Progress in Neurobiology
  33. Tau-targeting therapy in Alzheimer’s disease: Critical advances and future opportunities
    Guo, Yi, Li, Song, Zeng, Ling-Hui, Tan, Jun · 2022 · Ageing and Neurodegenerative Diseases
  34. Diversification of NAD biological role : the importance of location
    M. Di Stefano, Laura Conforti · 2013 · FEBS Journal
  35. Small Molecule Adenosine 5′-Monophosphate Activated Protein Kinase (AMPK) Modulators and Human Diseases
    Sandeep Rana, Elizabeth C. Blowers, Amarnath Natarajan · 2014 · Journal of Medicinal Chemistry
  36. Dietary Phytochemicals in Neuroimmunoaging: A New Therapeutic Possibility for Humans?
    Graziamaria Corbi, Valeria Conti, Sergio Davinelli, Giovanni Scapagnini, Amelia Filippelli, Nicola Ferrara · 2016 · Frontiers in Pharmacology
  37. Crucial Roles for SIRT2 and AMPA Receptor Acetylation in Synaptic Plasticity and Memory
    Guan Wang, Shaomin Li, James P. Gilbert, Howard J. Gritton, Zemin Wang, Zhangyuan Li, Xue Han, Dennis J. Selkoe, Heng‐Ye Man · 2017 · Cell Reports
  38. Decoding the non-coding RNAs in Alzheimer’s disease
    Nicole Schönrock, Jürgen Götz · 2012 · Cellular and Molecular Life Sciences
  39. Cellular factors modulating the mechanism of tau protein aggregation
    Sarah N. Fontaine, Jonathan J. Sabbagh, Jeremy D. Baker, Carlos R. Martinez Licha, April L. Darling, Chad A. Dickey · 2015 · Cellular and Molecular Life Sciences
  40. After the grape rush: Sirtuins as epigenetic drug targets in neurodegenerative disorders
    K. Huber, Giulio Superti‐Furga · 2011 · Bioorganic & Medicinal Chemistry
  41. Review of beneficial effects of resveratrol in neurodegenerative diseases such as Alzheimer's disease
    Justyna Komorowska, Mateusz Wątroba, Dariusz Szukiewicz · 2020 · Advances in Medical Sciences
  42. SIRT1 as a therapeutic target for Alzheimer’s disease
    Siew Ying Wong, Bor Luen Tang · 2016 · Reviews in the Neurosciences
  43. Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum
    Hamideh Shahheydari, Audrey Ragagnin, Adam K. Walker, Reka P. Toth, Marta Vidal, Cyril Jones Jagaraj, Emma R. Perri, Anna Konopka, Jessica M. Sultana, Julie D. Atkin · 2017 · Frontiers in Molecular Neuroscience
  44. Histone Deacetylase Inhibitor Alleviates the Neurodegenerative Phenotypes and Histone Dysregulation in Presenilins-Deficient Mice
    Ting Cao, Xiaojuan Zhou, Xianjie Zheng, Yue Cui, Joe Z. Tsien, Chunxia Li, Huimin Wang · 2018 · Frontiers in Aging Neuroscience
  45. Acetylated tau exacerbates learning and memory impairment by disturbing with mitochondrial homeostasis
    Liu, Qian, Wang, Xin, Hu, Yu, Zhao, Jun-Ning, Huang, Chun-Hui, Li, Ting, Zhang, Bing-Ge, He, Ye, Wu, Yan-Qing, Zhang, Zai-Jun et al. · 2023 · Redox Biology
  46. Stress Granules and Neurodegenerative Disorders: A Scoping Review
    Mohammad Reza Asadi, Marziyeh Sadat Moslehian, Hani Sabaie, Abbas Jalaiei, Soudeh Ghafouri‐Fard, Mohammad Naser Taheri, Maryam Rezazadeh · 2021 · Frontiers in Aging Neuroscience
  47. Sirtuins as Potential Therapeutic Targets for Mitigating Neuroinflammation Associated With Alzheimer’s Disease
    Kurukulasooriya Fernando, Y. Wijayasinghe · 2021 · Frontiers in Cellular Neuroscience
  48. SIRT1 exerts protective effects by inhibiting endoplasmic reticulum stress and NF-κB signaling pathways
    Kaixuan Zhao, Haoyue Zhang, Dong Yang · 2024 · Frontiers in Cell and Developmental Biology
  49. Behind the curtain of tauopathy: a show of multiple players orchestrating tau toxicity
    Yunpeng Huang, Zhihao Wu, Bing Zhou · 2015 · Cellular and Molecular Life Sciences
  50. Frontotemporal dementia: insights into the biological underpinnings of disease through gene co-expression network analysis
    Raffaele Ferrari, Paola Forabosco, Jana Vandrovcová, Juan Antonio Botía, Sebastian Guelfi, Jason D. Warren, Parastoo Momeni, Michael E. Weale, Mina Ryten, John Hardy · 2016 · Molecular Neurodegeneration
  51. The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection
    Rodrigo A. Quntanilla, Carola Tapia-Monsalves · 2020 · Current Neuropharmacology
  52. Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease
    Touqeer Ahmed, Saadia Zahid, Aamra Mahboob, Syeda Mehpara Farhat · 2016 · Current Neuropharmacology
  53. The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease
    Juanjuan Zhao, Dongxu Yue, Ya Zhou, Jia Li, Hairong Wang, Mengmeng Guo, Hualin Xu, Chao Chen, Jidong Zhang, Lin Xu · 2017 · Frontiers in Neurology
  54. Open‐Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy
    Lawren A. VandeVrede, Marian L. Dale, Scott Fields, Megan Frank, Emma B. Hare, Hilary W. Heuer, Kellie Keith, MARY E. KOESTLER, Peter Alexander Ljubenkov, Dana McDermott et al. · 2020 · Movement Disorders Clinical Practice
  55. Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization
    Hamad Yadikar, Isabel Torres, Gabrielle Aiello, Milin Kurup, Zhihui Yang, Fan Yu Lin, Firas H. Kobeissy, Richard A. Yost, Kevin Wang · 2020 · PLoS ONE
  56. TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy
    Alquezar, Carolina, Schoch, Kathleen M., Geier, Ethan G., Ramos, Eliana Marisa, Scrivo, Aurora, Li, Kathy H., Argouarch, Andrea R., Mlynarski, Elisabeth E., Dombroski, Beth, DeTure, Michael et al. · 2021 · Science Advances
  57. Beyond amyloid: Getting real about nonamyloid targets in Alzheimer's disease
    Karl Herrup, María C. Carrillo, Dale Schenk, Angela M. Cacace, Susan DeSanti, Robert T. Fremeau, Ratan V. Bhat, Marcie A. Glicksman, Patrick C. May, Russell Howard Swerdlow et al. · 2013 · Alzheimer s & Dementia
  58. The Role and Pathogenesis of Tau Protein in Alzheimer’s Disease
    Xiaoyue Hong, Linshu Huang, Fang Lei, Li Tian, Yi Luo, Mengliu Zeng, Zhuo Wang · 2025 · Biomolecules
  59. Intrinsic Tau Acetylation Is Coupled to Auto-Proteolytic Tau Fragmentation
    Todd J. Cohen, Brian H. Constance, Andrew W. Hwang, Michael James, Chao‐Xing Yuan · 2016 · PLoS ONE
  60. Molecular Mechanism of Nuclear Tau Accumulation and its Role in Protein Synthesis
    Miguel Portillo, Ekaterina Eremenko, Shai Kaluski, Alfredo García-Venzor, Lior Onn, Daniel Stein, Zeev Slobodnik, Adam Zaretsky, Uwe Ueberham, Monica Einav et al. · 2020 · Cell Reports
  61. Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology
    Jianping Guo, Ji Cheng, Brian J. North, Wenyi Wei · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  62. Elucidating Tau function and dysfunction in the era of cryo-EM
    Guy M. Lippens, Benoı̂t Gigant · 2019 · Journal of Biological Chemistry
  63. Distinct Conformers of Assembled Tau in Alzheimer's and Pick's Diseases
    Michel Goedert, Benjamin Falcon, Wenjuan Zhang, Bernardino Francesco Ghetti, Sjors H. W. Scheres · 2018 · Cold Spring Harbor Symposia on Quantitative Biology
  64. Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer’s Disease
    Huseby, Carol J., Hoffman, Claire N., Cooper, Grace L., Cocuron, Jean-Christophe, Alonso, Ana P., Thomas, Stefani N., Yang, Austin J., Kuret, Jeff · 2019 · Journal of Alzheimer’s Disease
  65. Oxidative Stress in Tauopathies: From Cause to Therapy
    Fernando Benito Bartolomé, Eva Carro, Carolina Alquézar · 2022 · Antioxidants
  66. Increased Risk of Aging-Related Neurodegenerative Disease after Traumatic Brain Injury
    Barker, Sarah, Paul, Bindu, Pieper, Andrew · 2023 · Biomedicines
  67. Phytochemicals targeting Alzheimer's disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action
    Zheng Zhao, Jun Yan, Lei Huang, Xue Yang · 2024 · Biomedicine & Pharmacotherapy
  68. Attenuation of β‐amyloid‐induced tauopathy via activation of CK2α/SIRT1: Targeting for cilostazol
    Hye Rin Lee, Hwa Kyoung Shin, So Youn Park, Hye Young Kim, Won Suk Lee, Byung Yong Rhim, Ki Whan Hong, Chi Dae Kim · 2013 · Journal of Neuroscience Research
  69. Sirt1: Def-eating senescence?
    Salvatore Fusco, Giuseppe Maulucci, Giovambattista Pani · 2012 · Cell Cycle
  70. SIRT1 deacetylase in aging‐induced neuromuscular degeneration and amyotrophic lateral sclerosis
    A. Zara Herskovits, Tegan A. Hunter, Nicholas David Maxwell, Katherine Pereira, Charles A. Whittaker, Gregorio Valdez, Leonard Guarente · 2018 · Aging Cell
  71. A combinatorial native MS and LC-MS/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modifications
    Friedel Drepper, Jacek Biernat, Senthilvelrajan Kaniyappan, Helmut E. Meyer, Eva‐Maria Mandelkow, Bettina Warscheid, Eckhard Mandelkow� · 2020 · Journal of Biological Chemistry
  72. Mechanical injuries of neurons induce tau mislocalization to dendritic spines and tau-dependent synaptic dysfunction
    Nicholas J. Braun, Katherine R. Yao, Patrick W. Alford, Dezhi Liao · 2020 · Proceedings of the National Academy of Sciences
  73. Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer’s Disease1
    Xiaoguang Liu, Michaeline L. Hebron, Sanjana Mulki, Chen Wang, Elizabeth Lekah, Dalila Ferrante, Wangke Shi, Bahjat T. Kurd-Misto, Charbel Moussa · 2019 · Journal of Alzheimer s Disease
  74. SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis
    Xueling Wang, Liyan Wu, Long Zhao, Lina Sun, Haiying Liu, Gang Liu, Guangju Guan · 2016 · Biomedicine & Pharmacotherapy
  75. Untangling the Tauopathy for Alzheimer’s disease and parkinsonism
    Hui-Yun Chang, Tzu‐Kang Sang, Ann‐Shyn Chiang · 2018 · Journal of Biomedical Science
  76. Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease
    Michał Wiciński, Anna Domanowska, Eryk Wódkiewicz, Bartosz Malinowski · 2020 · International Journal of Molecular Sciences
  77. Redox signaling and metabolism in Alzheimer's disease
    Mariana Inés Holubiec, Manuela Gellert, Eva-Maria Hanschmann · 2022 · Frontiers in Aging Neuroscience
  78. MicroRNAs in Vascular Eye Diseases
    Chi‐Hsiu Liu, Shuo Huang, William R. Britton, Jing Chen · 2020 · International Journal of Molecular Sciences
  79. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology
    Lixin Song, Sherry X. Lu, Xuesong Ouyang, Jerry P. Melchor, Julie Lee, Giuseppe Terracina, Xiaohai Wang, Lynn A. Hyde, J. Fred Hess, Eric M. Parker et al. · 2015 · Molecular Neurodegeneration
  80. Four-Repeat Tauopathies: Current Management and Future Treatments
    Lawren A. VandeVrede, Peter Alexander Ljubenkov, Julio C. Rojas, Ariane E. Welch, Adam L. Boxer · 2020 · Neurotherapeutics
  81. Resveratrol confers neuroprotection against high-fat diet in a mouse model of Alzheimer's disease via modulation of proteolytic mechanisms
    Sara Sarroca, Alaó Gatius, Eduard Rodrı́guez-Farré, David Vı́lchez, Mercè Pallàs, Christian Griñán‐Ferré, Coral Sanfeliu, Rubén Corpas · 2020 · The Journal of Nutritional Biochemistry
  82. Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium
    Seripa, Davide, Solfrizzi, Vincenzo, Imbimbo, Bruno P., Daniele, Antonio, Santamato, Andrea, Lozupone, Madia, Zuliani, Giovanni, Greco, Antonio, Logroscino, Giancarlo, Panza, Francesco · 2016 · Expert Review of Neurotherapeutics
  83. Evolutionarily conserved regulators of tau identify targets for new therapies
    Jiyoen Kim, María de Haro, Ismael Al‐Ramahi, Lorena Laura Garaicoechea, Hyun-Hwan Jeong, Jun Young Sonn, Bakhos Tadros, Zhandong Liu, Juan Botas, Huda Yahya Zoghbi · 2023 · Neuron
  84. Live‐Cell Studies of p300/CBP Histone Acetyltransferase Activity and Inhibition
    Beverley M. Rabbitts, Nicholas T. Crump, Daniel J. Peterson, Chandrani Mukherjee, Erin M. Bowers, Young‐Hoon Ahn, Minoru Yoshida, Jin Zhang, Louis C. Mahadevan, David J. Meyers et al. · 2012 · ChemBioChem
  85. APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer’s
    Anna Yang, Boris Kantor, Ornit Chiba‐Falek · 2021 · International Journal of Molecular Sciences
  86. The role of amyloidogenic protein oligomerization in neurodegenerative disease
    Gregor P. Lotz, Justin A. Legleiter · 2013 · Journal of Molecular Medicine
  87. Inhibition of HDAC6 Modifies Tau Inclusion Body Formation and Impairs Autophagic Clearance
    Janina Leyk, Olaf Goldbaum, Monika Noack, Christiane Richter‐Landsberg · 2014 · Journal of Molecular Neuroscience
  88. An acetylation mimicking mutation, K274Q, in tau imparts neurotoxicity by enhancing tau aggregation and inhibiting tubulin polymerization
    Jitendra Subhash Rane, Anuradha Ranjan Kumari, Dulal Panda · 2019 · Biochemical Journal
  89. Chronic Traumatic Encephalopathy: Update on Current Clinical Diagnosis and Management
    Kevin Pierre, Kyle A. Dyson, Abeer Dagra, Eric Williams, Ken M. Porche, Brandon Peter Lucke-Wold · 2021 · Biomedicines
  90. The Protective Mechanism of SIRT1 in the Regulation of Mitochondrial Biogenesis and Mitochondrial Autophagy in Alzheimer’s Disease
    Fan Ye, Anshi Wu · 2021 · Journal of Alzheimer s Disease
  91. Epigenetic Basis of Neuronal and Synaptic Plasticity
    Nina N. Karpova, Amanda J. Sales, Sâmia R.L. Joca · 2016 · Current Topics in Medicinal Chemistry
  92. Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
    Almudena Fuster-Matanzo, Félix Hernández, Jesús Ávila · 2018 · International Journal of Molecular Sciences
  93. Stimulation of SIRT1 Attenuates the Level of Oxidative Stress in the Brains of APP/PS1 Double Transgenic Mice and in Primary Neurons Exposed to Oligomers of the Amyloid-β Peptide
    Yang‐Ting Dong, Kun Cao, Long-Chun Tan, Xiaoling Wang, Xiaolan Qi, Yan Chun Xiao, Zhi-Zhong Guan · 2018 · Journal of Alzheimer s Disease
  94. TDP-43 drives synaptic and cognitive deterioration following traumatic brain injury
    Fei Gao, Mei Hu, Jian Zhang, Jack Hashem, Chu Chen · 2022 · Acta Neuropathologica
  95. miR-30a-5p induces Aβ production via inhibiting the nonamyloidogenic pathway in Alzheimer’s disease
    Ting Sun, Kaiyue Zhao, Mimin Liu, Zhongdi Cai, Li Zeng, Junxia Zhang, Zhuorong Li, Rui Liu · 2022 · Pharmacological Research
  96. Acetylation discriminates disease-specific tau deposition
    Pijush Chakraborty, Gwladys Rivière, Alina Hebestreit, Alain Ibáñez de Opakua, Ina Maja Vorberg, Loren B. Andreas, Markus Zweckstetter · 2023 · Nature Communications
  97. Nitrosylation of GAPDH augments pathological tau acetylation upon exposure to amyloid-β
    Tanusree Sen, Pampa Saha, Nilkantha Sen · 2018 · Science Signaling
  98. A silver lining for 24-hydroxycholesterol in Alzheimer's disease: The involvement of the neuroprotective enzyme sirtuin 1
    Gabriella Testa, Erica Staurenghi, Serena Giannelli, Simona Gargiulo, Michela Guglielmotto, Massimo Tabaton, Elena Tamagno, Paola Gamba, Gabriella Leonarduzzi · 2018 · Redox Biology
  99. AMPK: Potential Therapeutic Target for Alzheimer's Disease
    Luping Yang, Yijing Jiang, Lihong Shi, Dongling Zhong, Yuxi Li, Juan Li, Rongjiang Jin · 2019 · Current Protein and Peptide Science
  100. Epigenetic Treatment of Neurological Disease
    Steven G. Gray · 2011 · Epigenomics